Research progress of sarcopenic obesity and chronic liver disease.
10.3760/cma.j.cn501113-20220901-00489
- Author:
Lan Yan TANG
1
;
Li Zhi ZHOU
1
;
Pan ZHANG
1
Author Information
1. Department of Infection, the Third Xiangya Hospital of Central South University, Changsha 410013.
- Publication Type:Journal Article
- Keywords:
Liver disease;
Nutrition;
Prognosis;
Sarcopenia;
Sarcopenia obesity
- MeSH:
Humans;
Sarcopenia/complications*;
Body Composition/physiology*;
Obesity/complications*;
Risk Factors;
Liver Diseases/complications*;
Muscle, Skeletal
- From:
Chinese Journal of Hepatology
2023;31(4):445-448
- CountryChina
- Language:Chinese
-
Abstract:
Sarcopenia has attracted increasing attention with the study of nutrition in patients with liver disease. Sarcopenia is an independent risk factor for a poor prognosis of liver disease and is becoming increasingly common in patients with liver disease. Studies have shown that patients with liver disease and sarcopenic obesity have a worse prognosis than patients with liver disease and simple sarcopenia or obesity. In clinical practice, it is easy to recognize patients with malnutrition and decreased muscle mass, but we often ignore those patients with normal body weight or even obesity who will likewise experience muscle mass loss. Simply relying on the monitoring of body mass and body mass index to assess the nutritional and muscle status of patients with liver disease is not accurate. At present, our understanding of the relationship between chronic liver disease and sarcopenic obesity is still poorly understood. In this paper, the research progress on chronic liver disease, sarcopenia, and sarcopenic obesity in recent years is reviewed so as to provide a theoretical basis for improving the clinical prognosis of patients with liver disease.
